Статья

Phosphazide (nikavir) is a highly effective drug for the treatment of HIV/AIDS infection

G. Galegov,
2021

Convincing evidence for high therapeutic activity and tolerability of Phosphazide in the treatment of HIV/AIDS- infection is given. Phosphazide is currently used in various regimens of highly active antiretroviral therapy, as well as in the HIV therapy in patients with simultaneously acquired chronic hepatitis C or tuberculosis. Therapeutic possibilities of Phosphazide were clearly manifested in the prevention of HIV transmission from mother to child. There is every reason to use Phosphazide in first-line antiretroviral therapy.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • G. Galegov
    Federal State Budgetary Institution Federal Research Centre for Epidemiology and Microbiology Named after Honorary Academician N.F. Gamaleya, D.I. Ivanovsky Institute of Virology, Moscow, 123098, Russian Federation
Название журнала
  • Voprosy Virusologii
Том
  • 62
Выпуск
  • 1
Страницы
  • 5-11
Ключевые слова
  • 3'-azido-2',3'-dideoxythymidine 5'-H-phoshonate; anti human immunodeficiency virus agent; phosphonic acid derivative; zidovudine; analogs and derivatives; drug effect; female; fetus; genetics; highly active antiretroviral therapy; human; Human immunodeficiency virus; Human immunodeficiency virus infection; metabolism; pregnancy; pregnancy complication; prevention and control; procedures; transmission; treatment outcome; vertical transmission; virology; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Fetus; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Zidovudine
Издатель
  • Meditsina Publishers
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus